key: cord-0947676-8d2nqta5
authors: Nomura, Takushi; Yamamoto, Hiroyuki; Nishizawa, Masako; Hau, Trang Thi Thu; Harada, Shigeyoshi; Ishii, Hiroshi; Seki, Sayuri; Nakamura-Hoshi, Midori; Okazaki, Midori; Daigen, Sachie; Kawana-Tachikawa, Ai; Nagata, Noriyo; Iwata-Yoshikawa, Naoko; Shiwa, Nozomi; Iida, Shun; Katano, Harutaka; Suzuki, Tadaki; Park, Eun-Sil; Maeda, Ken; Suzaki, Yuriko; Ami, Yasushi; Matano, Tetsuro
title: Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques
date: 2021-05-26
journal: bioRxiv
DOI: 10.1101/2021.05.26.445769
sha: 7f8404bece5d85a9f012f5465770b23d59182f91
doc_id: 947676
cord_uid: 8d2nqta5

SARS-CoV-2 infection presents clinical manifestations ranging from asymptomatic to fatal respiratory failure. Despite the induction of functional SARS-CoV-2-specific CD8+ T-cell responses in convalescent individuals, the role of virus-specific CD8+ T-cell responses in the control of SARS-CoV-2 replication remains unknown. In the present study, we show that subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques. Eight macaques were intranasally inoculated with 105 or 106 TCID50 of SARS-CoV-2, and three of the eight macaques were treated with a monoclonal anti-CD8 antibody on days 5 and 7 post-infection. In these three macaques, CD8+ T cells were undetectable on day 7 and thereafter, while virus-specific CD8+ T-cell responses were induced in the remaining five untreated animals. Viral RNA was detected in nasopharyngeal swabs for 10-17 days post-infection in all macaques, and the kinetics of viral RNA levels in pharyngeal swabs and plasma neutralizing antibody titers were comparable between the anti-CD8 antibody treated and untreated animals. SARS-CoV-2 RNA was detected in the pharyngeal mucosa and/or retropharyngeal lymph node obtained at necropsy on day 21 in two of the untreated group but undetectable in all macaques treated with anti-CD8 antibody. CD8+ T-cell responses may contribute to viral control in SARS-CoV-2 infection, but our results indicate possible containment of subacute viral replication in the absence of CD8+ T cells, implying that CD8+ T-cell dysfunction may not solely lead to viral control failure. Author Summary SARS-CoV-2 infection presents a wide spectrum of clinical manifestations ranging from asymptomatic to fatal respiratory failure. The determinants for failure in viral control and/or fatal disease progression have not been elucidated fully. Both acquired immune effectors, antibodies and CD8+ T cells, are considered to contribute to viral control. However, it remains unknown whether a deficiency in either of these two arms is directly linked to failure in the control of SARS-CoV-2 replication. In the present study, to know the requirement of CD8+ T cells for viral control after the establishment of infection, we examined the effect of CD8+ cell depletion by monoclonal anti-CD8 antibody administration in the subacute phase on SARS-CoV-2 replication in cynomolgus macaques. Unexpectedly, our analysis revealed no significant impact of CD8+ cell depletion on viral replication, indicating that subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells. CD8+ T-cell responses may contribute to viral control in SARS-CoV-2 infection, but this study suggests that CD8+ T-cell dysfunction may not solely lead to viral control failure or fatal disease progression.

SARS-CoV-2 infection presents clinical manifestations ranging from asymptomatic to fatal 23 respiratory failure. Despite the induction of functional SARS-CoV-2-specific CD8 + T-cell 24 responses in convalescent individuals, the role of virus-specific CD8 + T-cell responses in the 25 control of SARS-CoV-2 replication remains unknown. In the present study, we show that 26 subacute SARS-CoV-2 replication can be controlled in the absence of CD8 + T cells in 27 cynomolgus macaques. Eight macaques were intranasally inoculated with 10 5 or 10 6 TCID50 of 28 SARS-CoV-2, and three of the eight macaques were treated with a monoclonal anti-CD8 29 antibody on days 5 and 7 post-infection. In these three macaques, CD8 + T cells were 30 undetectable on day 7 and thereafter, while virus-specific CD8 + T-cell responses were induced 31 in the remaining five untreated animals. Viral RNA was detected in nasopharyngeal swabs for 32 10-17 days post-infection in all macaques, and the kinetics of viral RNA levels in pharyngeal 33 swabs and plasma neutralizing antibody titers were comparable between the anti-CD8 antibody 34 treated and untreated animals. SARS-CoV-2 RNA was detected in the pharyngeal mucosa 35

Introduction 57

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome 58 coronavirus 2 (SARS-CoV-2) has rapidly spread resulting in a major pandemic [1] . SARS-CoV-59 2 transmission occurs via the respiratory route, and the average incubation period from infection 60 to symptom onset has been estimated to be 5 days [2] . SARS-CoV-2 infection presents a wide 61 spectrum of clinical manifestations ranging from asymptomatic to fatal respiratory failure [3] . 62

Multiple cofounding factors such as age and underlying diseases are associated with COVID-63 the second experiment showed comparable levels of viral RNAs and sgRNAs in 118 nasopharyngeal swabs on day 2 compared to the three macaques inoculated with 10 6 or 10 5 119 TCID50 of SARS-CoV-2 in the first experiment ( Fig 1A and Fig 2A) . Indeed, no significant 120 difference in RNA levels in nasopharyngeal swabs on day 5 was observed between the first 121 three and the second five animals (Fig 1E) . No clear difference in viral loads in either 122 nasopharyngeal or throat swabs on days 2 and 5 was observed between macaques inoculated 123 with 10 6 (n = 3) and 10 5 (n = 5) TCID50 of SARS-CoV-2 ( Fig 1C and 1D and Fig 2C and 2D) . 124 Viral RNA in nasopharyngeal swabs was detectable until day 14 in N021 and day 10 in N022 125 following inoculation (Fig 1A, 1C , and 1D). SARS-CoV-2 sgRNAs in nasopharyngeal swabs 126 were detected until day 5 in N021 and day 7 in N022 following inoculation (Fig 2A, 2C , and 127 2D). Collectively, in the first and second experiments, intranasal inoculation of cynomolgus 128 macaques with 10 6 or 10 5 TCID50 of SARS-CoV-2 resulted in viral replication with viral RNA 129 detectable for 10-17 days in nasopharyngeal swabs. 130 8 versus the five untreated Group N macaques. 143

We also examined whether virus could be recovered from individual swab samples (Table  144 2). SARS-CoV-2 was recovered from nasopharyngeal and throat swabs from all eight animals 145 intranasally inoculated with either 10 6 or 10 5 TCID50. Virus was recovered for 2-12 days in anti-146 CD8 antibody-untreated macaques (until day 2 in N021, day 5 in N013 and N022, day 7 in 147 N011, and day 12 in N012) and for 2-7 days in anti-CD8 antibody-treated macaques (until day 148 2 in D024 and day 7 in D023 and D025 (Table 3) . Virus-specific CD8 + T-cell responses were undetectable in 241

PBMCs but efficiently detected in the submandibular lymph nodes on day 21 (Fig 5) , 242

suggesting localized virus replication in the pharyngeal mucosa. 243

The sample size used in this study is relatively limited (three anti-CD8 antibody treated 244 animals and five untreated controls). However, these three animals exhibited similar levels of 245 pharyngeal viral loads before the anti-CD8 antibody treatment, and again showed similar levels 246 of viral loads after CD8 + cell depletion. Neither enhancement of viral replication nor delay in 247 viral control was observed. Therefore, this study provides sufficient evidence for our conclusion. 248

In summary, the present study showed that subacute SARS-CoV-2 replication can be 249 CoV-2 wk-521 at a dose of 10 6 (exactly 7.5 x 10 5 ) TCID50 (1.4 x 10 9 RNA copies) (n = 3), 10 5 274 (exactly 7.5 x 10 4 ) TCID50 (n = 5), or 10 4 (exactly 7.5 x 10 3 ) TCID50 (n = 1) ( Table 1) . Three (DST micro-T; Star-Oddi) that was set intraperitoneally under ketamine anesthesia at least five 279 days prior to virus inoculation. Macaques were euthanized and subjected to necropsy on day 14 280 or 21 post-infection (Table 1) d0  d2  d5  d7  d9/10  d12  d14  d17  d21   N011  -+  +  +  ------+  +  ------N012 - 

d21 ----+ a RNA was extracted from individual tissues and subjected to RT-PCR to detect SARS-CoV-2 532

RNA. + indicates detection of viral RNA. 533 

Broadening of 470 virus-specific CD8+ T-cell responses is indicative of residual viral replication in aviremic 471 SIV controllers

A-D) Changes in viral RNA levels in nasopharyngeal (A, C, D) and throat (B) swabs after

SARS-CoV-2 infection in all animals (A, B) or those infected with 10 6 (C) or 10 5 (D)

SARS-CoV-2. The lower limit of detection was approximately 3 x 10 3 copies/swab

Comparison of viral RNA levels in nasopharyngeal swabs at day 5 post-infection between 10 6

TCID50-infected and 10 5 TCID50-infected macaques. No significant difference was observed

Comparison of viral RNA levels in nasopharyngeal swabs at days 5 (left), 7 (middle), and 491 9-12 (right) post-infection between Group N and D animals infected with 10 6 or 10 5 TCID50 of 492 SARS-CoV-2

Fig 2. Viral subgenomic RNA levels in swabs

Changes in viral sgRNA levels in nasopharyngeal (A, C, D) and throat (B) swabs after SARS-496

CoV-2 infection in all animals (A, B) or those infected with 10 6 (C) or 10 5 (D)

CoV-2. The lower limit of detection was approximately 3 x 10 3 copies/swab